cyclosporine has been researched along with Anterior Choroidal Artery Infarction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damaskos, C; Daskalopoulou, A; Dimopoulos, C; Garmpis, N; Georgopoulos, S; Kontzoglou, K; Moraitis, S; Nikiteas, N; Papadakis, M; Papaspirou, I; Perrea, D | 1 |
| Curè, J; Flanagan, C; Kline, L | 1 |
| Borlongan, CV; Hess, DC; Yu, G | 1 |
| Isshiki, A; Matsumoto, E; Matsumoto, S; Murozono, M; Watanabe, Y | 1 |
| Emminger, W; Freilinger, M; Huemer, M; Trattnig, S; Wandl-Vergesslich, K | 1 |
| Janelidze, S; Kuroda, S; Siesjö, BK | 1 |
| Kelly, JS; Sharkey, J | 1 |
2 review(s) available for cyclosporine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Cerebral blindness.
Topics: Alzheimer Disease; Blindness, Cortical; Brain Diseases; Brain Injuries; Cerebral Infarction; Creutzfeldt-Jakob Syndrome; Cyclosporine; Electrodiagnosis; Humans; Immunosuppressive Agents; Occipital Lobe; Seizures; Tacrolimus; Visual Cortex | 2009 |
Immunosuppressants-ligands as neuroprotectants.
Topics: Cerebral Infarction; Cyclosporine; Humans; Immunosuppressive Agents; Ligands; Neuroprotective Agents; Stroke; Tacrolimus | 2001 |
5 other study(ies) available for cyclosporine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Expression of S100B Protein in Ischemia/Reperfusion-Induced Brain Injury After Cyclosporine Therapy: A Biochemical Serum Marker with Prognostic Value?
Topics: Animals; Biomarkers; Brain; Brain Injuries; Brain Ischemia; Cerebral Infarction; Cyclosporine; Male; Neuroprotective Agents; Prognosis; Rats; Rats, Wistar; Reperfusion Injury; S100 Calcium Binding Protein beta Subunit | 2019 |
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome | 2004 |
Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cerebral Infarction; Cyclosporine; Dose-Response Relationship, Drug; Ischemic Attack, Transient; Male; Mice; Mice, Knockout; Neuroprotective Agents; Time Factors | 2004 |
Kinking and stenosis of the carotid artery associated with homolateral ischaemic brain infarction in a patient treated with cyclosporin A.
Topics: Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone | 1998 |
The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.
Topics: Analysis of Variance; Animals; Arterial Occlusive Diseases; Cerebral Infarction; Cyclosporine; Hyperglycemia; Immunosuppressive Agents; Ischemic Attack, Transient; Male; Neuroprotective Agents; Rats; Rats, Wistar; Tacrolimus; Treatment Outcome | 1999 |